Results 151 to 160 of about 41,786 (283)

Alzheimer’s disease molecular subtypes in a clinical trial cohort

open access: yesAlzheimer's &Dementia, Volume 21, Issue S5, December 2025.
Abstract Background Alzheimer’s disease (AD) exhibits significant molecular heterogeneity, which poses challenges for treatment development. Understanding this heterogeneity is essential for creating more effective therapies and improving patient outcomes.
Pieter Jelle Visser   +6 more
wiley   +1 more source

Association between Klotho levels in cerebrospinal fluid and choroid plexus enlargement in neurodegeneration. [PDF]

open access: yesFront Aging Neurosci
Sacchi L   +15 more
europepmc   +1 more source

Increased Incidence of Choroid Plexus Carcinoma Due to the Germline TP53 R337H Mutation in Southern Brazil

open access: gold, 2011
Gislaine Custódio   +8 more
openalex   +2 more sources

Sternberg's canal defect: meningitis as the initial presentation in a patient with choroid plexus cyst incidentaloma. Illustrative case. [PDF]

open access: yesJ Neurosurg Case Lessons
Ayasa LA   +8 more
europepmc   +1 more source

Brain drug delivery, drug metabolism, and multidrug resistance at the choroid plexus [PDF]

open access: bronze, 2000
Jean‐François Ghersi‐Egea   +1 more
openalex   +1 more source

Lecanemab therapy Leads to Glymphatic Function Maintenance and Free Water Homeostasis in Alzheimer’s Disease: Evidence from a Multidimensional Real‐World Study

open access: yesAlzheimer's &Dementia, Volume 21, Issue S7, December 2025.
Abstract Background The glymphatic system’s role in mediating anti‐amyloid therapy efficacy remains underexplored. This study investigates the effects of Lecanemab on glymphatic function, free water distribution, and cognition performance in Alzheimer’s disease.
Ruinan Shen   +8 more
wiley   +1 more source

ATP7A Gene Addition to the Choroid Plexus Results in Long-term Rescue of the Lethal Copper Transport Defect in a Menkes Disease Mouse Model [PDF]

open access: hybrid, 2011
Anthony Donsante   +9 more
openalex   +1 more source

Home - About - Disclaimer - Privacy